{"name":"Allievex Corporation","slug":"allievex-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPRXlMVzJLZHJ4VU9GOFI1TDZGNG1SbmZJR3liTEc2VER4ZHZpTjVUVG5aaVhNVnpjd3RERTRUYmdOOHJEaGNHMWw0VnpzdWpyNjV2YmxtV0pmS19jWGhDZGRLX2piWnNmc0pHR3NoWFNELUlJb2ZNY1U4OWNDaFA2d21yNk5BVXdnQWRnQ1RweVc1SWZYWXRORg?oc=5","date":"2026-03-09","type":"pipeline","source":"Fierce Pharma","summary":"Spruce hooks a commercial chief to prep for rare disease launch - Fierce Pharma","headline":"Spruce hooks a commercial chief to prep for rare disease launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxORHc1Y2tIbEtJNm44cmw0V1J6WFpwd2xRNzlzanh2OGx5TEFSOElZTGFnYWxJVE5kS1hfcnNHaUhqMC1SSWJwMVpIdnBnMEF3R1JVRnZMMjVxeU5WMGdJQVJoc2FxTzc4S1NacWc0QnY3Wm9rODNqV045cXMxdjJVQUV6SXQwYXd2M3ZLUXMyQ2t4cnJIb1RnZ0VDdTBWZWs?oc=5","date":"2025-07-14","type":"pipeline","source":"BioWorld News","summary":"Ultragenyx hit again, this time with a CRL in rare disease - BioWorld News","headline":"Ultragenyx hit again, this time with a CRL in rare disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNcTNDc2RqR1c4eEQ3SmtoNUZWMDI3OEt5UVdVQ21Ebm0xOHBfTEEtR0FnVlBmUUJHSmRsWlBUTXctZC0xX2dzR3NaRTFUV1JzazQyWmtQYlJ2dU83UHZmaGdFaTVHMm9mLWVTLVY2X1MzS09kak9mYkg2NzBJSVdIdkI0YmJTUnd6S0FicVM1RlhaRTZqSU14Tk54Vm1RVFl0X2pBV2RwQ3c4dWdzanc?oc=5","date":"2025-04-15","type":"regulatory","source":"Fierce Biotech","summary":"Spruce smartens up pipeline with deal for BioMarin asset, plans 2026 approval filing - Fierce Biotech","headline":"Spruce smartens up pipeline with deal for BioMarin asset, plans 2026 approval filing","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOWjlmRk1GcHVIQWV3RXJ5dG9tUUVBczhRcC1zanpVSzdwWDZmNjBjeW96bjNfMUsyek9iOVZ4ZmlFTkRlNkRGWkl2UzZqZmxVdm5KTUcxV1M3TEhNN3RRTGM3WXR6U1ViTHF1eDJVeHJqWTNoRVFlY0VTUW5hN3hkZXViSmpUM0lsWEEybFZ1VlZyOUlIZjdubDFWdk0tTXc4X0hBQUwyNzl1UzlXZ3c?oc=5","date":"2025-04-15","type":"deal","source":"The Business Journals","summary":"With BioMarin deal, Spruce Biosciences hits reset on rare-disease drug - The Business Journals","headline":"With BioMarin deal, Spruce Biosciences hits reset on rare-disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNX1Fya3hGRW9lRkFEem85bTY0Qld3eU5CcVR0alh0U1BCOTgyUUQ4d3BLcnB0NmlDQk9Pbm5VNHktWFE3a3BwMDdqTDVheFZibzg5VldmX0cxVkYyTEVfZEw1NHh0SGpvMjV2cGQtcEtxTDNVT3pBaFBHWTBtYlpabHMtSnJXaDh3UVBPRGNmVGRvZ2FhSHY0aWpfOTdKenl5dnRpRmhtQ2x4d0x3RDFYbG1WdWxELTlTZjNV0gFyQVVfeXFMT1FFZFpGNUZGT0h1dGpuNlVCN2hKS2Z5Mi13YkxtR1FNNnRIeWpyQkZ6MUhMNkUwbm9LUTlTQTd1eXBwaVpOSkRRLTAyVUFkc2FVYm5hR3draFFnek9qakpHMGN4Y0FsWjYwcWJSYVFsLUFB?oc=5","date":"2024-07-24","type":"pipeline","source":"Law360","summary":"Allievex To Liquidate In Chancery's Bankruptcy Alternative - Law360","headline":"Allievex To Liquidate In Chancery's Bankruptcy Alternative - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNdkhnSFc4NFNjQXhKQmJ6eGo0dXloMXJDVWdMRkQtR2FBTHIwcjVBTWRUbzBneHB5allIdkctckZLWXRxRmZ6bWFWQldxS2pfQk5VLXJsTjN1UjFXejFsRy1yTW1pdzZFNlNFWU9NQW1FT3JKTEZDYzlYWDZ0LVJTYlZaVWZDcFZvRkt5V0V5aDBXb3RWM25vcUpvVWpnMy1WRnMtTGhUbUpXeFJhWjQzMS1DRVJoWGd3OGhMUzY0aTdmaGpaQ2FlS1N3TnNJQ2ZwSW04?oc=5","date":"2020-08-08","type":"pipeline","source":"Faegre Drinker Biddle & Reath LLP","summary":"Allievex Corporation Enters Licensing Agreement With BioMarin Pharmaceutical - Faegre Drinker Biddle & Reath LLP","headline":"Allievex Corporation Enters Licensing Agreement With BioMarin Pharmaceutical - Faegre Drinker Biddle & Reath LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQWTNLSXVpRzNFRVEzbXJ5UkFReGdLQ1NQbWpOdTlqNVM3d2I5V1YxT0Y4UGJMUGJmT0ZvT3dOYjBwcFVTTWl5TmFiXzRFYmMxRzFWWk5vemxRZmhSU2EzcnU3TEpjNlR3SVBGZTZCcTE5Vlhrb3F2QUtGYURJS3hqbkZhLS1BbFQ3RjA4SnpER0lzR285S2xnRktRXzhVQktCcTVIZ2tpUGxmbVVYbjRsdUZSbWtMSGlaVEV4YTQ2bHBpclE3bzdva190UGc0UQ?oc=5","date":"2019-10-23","type":"pipeline","source":"PR Newswire","summary":"Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings - PR Newswire","headline":"Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}